Dr. Abdallah Daar, Professor of Public Health at the University of Toronto and a Genome Canada Board member since 2012, has been appointed to a new Scientific Advisory Board of the United Nations. Dr. Daar is one of twenty-six eminent scientists appointed to the Board, representing natural, social and human sciences and engineering.
Dr. Fabrice Brunet, Chief Executive Officer at Sainte-Justine UHC, and Marc LePage, President and CEO of Génome Québec, are extremely proud to announce the launch of Canada’s first integrated clinical genomic centre in pediatrics, an initiative currently at the forefront of global efforts in this area. "We are honoured to have the opportunity to make this partnership a reality in the presence of the Québec Premier, Pauline Marois, and Dr.
Genome Canada applauds the federal government’s Speech from the Throne, commending the government’s pledge to protect and promote traditional resource sectors.
The goal of the “Research Catalyst Network: Expediting collaboration between basic and clinician scientists in functional studies of novel rare disease genes” is to establish a national consortium that will enable clinical geneticists who are identifying rare disease gene mutations to collaborate with model organism researchers with expertise in the cognate gene’s function.
Canada’s federal research granting agencies—the Social Sciences and Humanities Research Council (SSHRC), the Natural Sciences and Engineering Research Council (NSERC), the Canadian Institutes of Health Research (CIHR), as well as the Canada Foundation for Innovation (CFI), and in collaboration with Genome Canada—have joined forces to help address digital infrastructure challenges through the consultation document
Hundreds of researchers from North America, Europe, Australia and Asia have joined together in a consortium to identify the genetic basis of the five most common forms of cancer – breast, prostate, lung, ovarian and colorectal. The group, called the OncoArray Consortium, developed a new customized genotyping tool – the OncoArray – manufactured by the U.S. genomics firm Illumina, Inc.